ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
2,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,Y
5,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
6,1,Oesophageal obstruction,Oesophageal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
6,2,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,Y
7,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
8,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
8,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
10,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
10,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
11,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
12,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
13,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
13,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
13,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
13,4,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
13,5,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
13,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
14,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
14,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
14,3,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
15,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
15,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
15,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
15,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
15,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
16,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
17,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
17,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
19,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
20,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
20,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
20,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
20,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
20,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
21,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
21,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
21,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
22,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,2,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
22,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
23,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
23,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
24,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
24,2,Ventricular failure,Heart failures NEC,Heart failures,Card,Y
25,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
25,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
25,3,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
25,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
26,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
26,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
26,3,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
26,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
26,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
27,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,3,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
27,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
27,5,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
28,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
28,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
28,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
29,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
29,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
29,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
30,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
30,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
30,3,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
31,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
31,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
32,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
32,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
33,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
33,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
33,3,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
33,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
33,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
33,7,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
33,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
33,9,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
33,10,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
33,11,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
34,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
34,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
35,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
35,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
36,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
37,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
38,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
38,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
38,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
39,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
39,3,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
40,1,Blood bilirubin decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
40,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
40,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
40,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
40,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
40,6,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
40,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
41,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
41,2,Blood electrolytes abnormal,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
41,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
41,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
41,6,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
42,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
42,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
42,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
42,4,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
42,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
42,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
43,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
43,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
43,3,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
44,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
44,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
44,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
45,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
45,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
45,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
45,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
45,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
45,7,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
45,8,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
45,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
45,10,Urinary hesitation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
45,11,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
46,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
46,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
46,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
46,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
46,5,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
46,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
46,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
47,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
47,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
47,3,Lung adenocarcinoma stage IV,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
48,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
48,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
48,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
48,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
48,5,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
49,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
50,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
51,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
51,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
51,3,Oesophageal spasm,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
52,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
52,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
53,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
53,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
53,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
53,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
53,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
54,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
54,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
54,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
54,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
54,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
54,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
54,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
54,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
54,10,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
54,11,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
54,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
55,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
55,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
55,3,Non-small cell lung cancer metastatic,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
55,4,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
56,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
56,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
57,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
57,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
57,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
58,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
59,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
59,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
59,3,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
60,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
60,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
60,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
61,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
62,1,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
62,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
63,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
63,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
63,3,Nephrogenic systemic fibrosis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
63,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
63,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
64,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
64,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
64,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
65,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
65,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
65,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
65,4,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
65,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
66,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
66,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
66,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
67,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
68,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
68,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
68,3,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
69,1,Diverticulum intestinal,Diverticula,Diverticular disorders,Gastr,N
69,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
69,3,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
69,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
69,5,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
69,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
70,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
70,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
70,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
70,4,Electrocardiogram ST-T segment abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
70,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
70,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
70,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
71,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
71,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
71,4,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
72,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
72,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
72,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
72,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
72,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
72,6,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
72,7,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
72,8,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
73,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
73,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
73,3,Non-small cell lung cancer metastatic,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
74,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
74,2,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
74,3,Lymphangiosis carcinomatosa,Metastases to specified sites,Metastases,Neopl,N
74,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
74,5,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
74,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
74,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
75,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
76,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
77,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
78,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
78,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
78,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
78,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
79,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
79,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
80,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
80,2,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
80,3,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
81,1,Cerebral congestion,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
81,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
81,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
82,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
82,2,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
83,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
84,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
84,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
84,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
84,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
84,5,Non-small cell lung cancer stage IV,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
84,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
84,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
84,8,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
85,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
85,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
86,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
87,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
88,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
88,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
88,3,Hypogonadism male,Male gonadal function disorders,Endocrine disorders of gonadal function,Endo,N
88,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
89,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
89,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
89,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
90,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
91,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
91,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
91,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
91,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
91,5,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
92,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
92,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
93,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
93,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
94,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
95,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
95,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
96,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
96,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
96,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
96,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
97,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
97,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
97,3,Headache,Headaches NEC,Headaches,Nerv,N
97,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
97,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
97,6,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
98,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
99,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
99,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
99,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
99,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
99,5,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
99,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
100,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
100,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
101,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
102,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
103,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
103,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
103,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
103,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
104,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
104,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
104,3,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
104,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
104,5,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
104,6,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
104,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
105,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
105,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
105,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
105,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
106,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
106,2,Oesophagitis ulcerative,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
107,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
107,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
107,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
107,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
108,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
108,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
109,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
109,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
110,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
110,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
110,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
110,4,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
110,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
110,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
110,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
111,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
111,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
111,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
112,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
112,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
112,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
113,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
114,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
114,2,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
115,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
116,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
116,3,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
116,4,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
116,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
116,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,7,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
116,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
116,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
116,10,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
116,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
117,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
117,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
117,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
118,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
118,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
118,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
118,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
118,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
118,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
118,7,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
118,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
118,9,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
118,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
118,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
118,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
118,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
118,14,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
119,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
119,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
120,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
121,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
121,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
121,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
121,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
121,5,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
121,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
121,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
121,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
121,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
121,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
121,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
121,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
122,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
122,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
122,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
123,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
123,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
124,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
124,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
124,3,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
124,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
124,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
125,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
125,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
126,1,Visual acuity reduced transiently,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
126,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
127,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
128,1,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
129,1,Headache,Headaches NEC,Headaches,Nerv,N
129,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
129,3,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
130,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
131,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
131,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
132,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
132,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
132,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
132,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
132,5,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
133,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
134,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
134,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
134,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
134,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
134,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
135,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
135,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
135,3,Haemofiltration,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
135,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
135,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
135,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
135,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
135,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
135,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
135,10,Systemic candida,Candida infections,Fungal infectious disorders,Infec,N
136,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
137,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
137,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
137,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
137,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
137,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
137,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
137,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
138,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
138,2,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
139,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
139,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
139,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
139,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
139,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
139,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
139,7,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
139,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
139,9,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
139,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
139,11,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
139,12,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
139,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
139,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
139,15,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
139,16,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
139,17,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
140,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
140,2,Retinal deposits,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
141,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
141,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
142,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
142,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
143,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
144,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
144,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
144,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
145,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
145,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
145,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
146,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
146,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
146,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
147,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
147,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
148,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
149,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
149,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
150,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
151,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
151,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
151,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
151,4,Nephritis,Nephritis NEC,Nephropathies,Renal,N
151,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
152,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
153,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
153,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
153,3,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
153,4,Headache,Headaches NEC,Headaches,Nerv,N
153,5,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
153,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
153,7,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
153,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
153,9,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
153,10,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
154,1,Vitreous detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
155,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
155,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
155,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
155,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
155,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
155,6,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
155,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
156,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
156,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
156,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
156,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
156,5,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
157,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
158,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
158,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
158,3,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
158,4,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
158,5,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
158,6,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
158,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
159,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
159,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
159,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
159,4,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
159,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
159,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
160,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
160,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
160,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
161,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
161,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
161,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
161,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
161,5,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
161,6,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
162,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
162,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
163,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
163,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
163,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
164,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
165,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
166,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
166,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
167,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
168,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
168,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
168,3,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
168,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
169,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
169,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
170,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
171,1,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
171,2,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
172,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
172,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
172,3,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
172,4,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
172,5,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
172,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
172,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
173,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
173,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
173,3,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
173,4,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
173,5,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
173,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
173,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
174,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
174,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
174,3,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
174,4,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
174,5,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
174,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
174,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
175,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
